STOCK TITAN

[8-K] The European Equity Fund, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Schedule 13D/A Amendment No. 6 for Gabelli Healthcare & Wellness Rx Trust (GRX) Preferred Shares discloses updated ownership information for multiple Gabelli-related entities and individuals.

Aggregate ownership: The Reporting Persons now hold 1,514,000 preferred shares, equal to 45.49 % of the 3,328,500 shares outstanding as of 30 Jun 2025. Key positions include:

  • Associated Capital Group (AC): 400,000 shares – 12.02 %
  • GAMCO Investors (GBL): 400,000 shares – 12.02 %
  • Mario J. Gabelli (individual): 400,000 shares – 12.02 %
  • Gabelli Foundation: 314,000 shares – 9.43 %

Recent transactions (26 Jun 2025): Several entities surrendered a total of 1,440,000 preferred shares (Series E & Series G) at $10.00 per share under the Fund’s put right to redeem up to 100 % of its outstanding cumulative preferred stock. The largest single surrender was 830,000 shares by Mario J. Gabelli.

Post-transaction, the group retains a controlling minority of the preferred class, maintaining significant influence over matters requiring preferred-shareholder approval. All reporting persons exercise sole voting and dispositive power over their respective holdings; no shared power is reported. No new legal proceedings or changes in control arrangements were disclosed.

Implications for investors: While the surrender materially reduces absolute ownership, the group’s collective stake remains large at 45 %. The buy-back at par ($10) may signal limited upside in the current preferred valuation and could affect liquidity of the remaining float. However, continued alignment of interests between the Gabelli entities and preferred shareholders persists.

Emendamento No. 6 al Schedule 13D/A per le Azioni Preferenziali di Gabelli Healthcare & Wellness Rx Trust (GRX) rivela informazioni aggiornate sulla proprietà di più entità e individui legati a Gabelli.

Proprietà complessiva: Le Persone che Segnalano detengono ora 1.514.000 azioni preferenziali, pari al 45,49% delle 3.328.500 azioni in circolazione al 30 giugno 2025. Le posizioni principali includono:

  • Associated Capital Group (AC): 400.000 azioni – 12,02%
  • GAMCO Investors (GBL): 400.000 azioni – 12,02%
  • Mario J. Gabelli (individuale): 400.000 azioni – 12,02%
  • Gabelli Foundation: 314.000 azioni – 9,43%

Transazioni recenti (26 giugno 2025): Diverse entità hanno ceduto un totale di 1.440.000 azioni preferenziali (Serie E & Serie G) a 10,00 $ per azione nell’ambito del diritto di rimborso del Fondo per riscattare fino al 100% delle azioni preferenziali cumulative in circolazione. La singola cessione più rilevante è stata di 830.000 azioni da parte di Mario J. Gabelli.

Dopo la transazione, il gruppo mantiene una minoranza di controllo della classe preferenziale, conservando un’influenza significativa sulle questioni che richiedono l’approvazione degli azionisti preferenziali. Tutte le persone che segnalano esercitano potere di voto e decisionale esclusivo sulle rispettive partecipazioni; non è stato riportato alcun potere condiviso. Non sono stati divulgati nuovi procedimenti legali o cambiamenti negli accordi di controllo.

Implicazioni per gli investitori: Sebbene la cessione riduca in modo significativo la proprietà assoluta, la quota collettiva del gruppo resta elevata al 45%. Il riacquisto a valore nominale (10 $) potrebbe indicare un potenziale limitato di apprezzamento nell’attuale valutazione delle azioni preferenziali e influire sulla liquidità del flottante residuo. Tuttavia, permane un allineamento continuo degli interessi tra le entità Gabelli e gli azionisti preferenziali.

Enmienda No. 6 al Schedule 13D/A para las Acciones Preferentes de Gabelli Healthcare & Wellness Rx Trust (GRX) revela información actualizada sobre la propiedad de múltiples entidades e individuos relacionados con Gabelli.

Propiedad agregada: Las Personas que Informan ahora poseen 1.514.000 acciones preferentes, equivalentes al 45,49% de las 3.328.500 acciones en circulación al 30 de junio de 2025. Las posiciones clave incluyen:

  • Associated Capital Group (AC): 400.000 acciones – 12,02%
  • GAMCO Investors (GBL): 400.000 acciones – 12,02%
  • Mario J. Gabelli (individual): 400.000 acciones – 12,02%
  • Gabelli Foundation: 314.000 acciones – 9,43%

Transacciones recientes (26 de junio de 2025): Varias entidades entregaron un total de 1.440.000 acciones preferentes (Series E y G) a 10,00 $ por acción bajo el derecho del Fondo para redimir hasta el 100% de sus acciones preferentes acumulativas en circulación. La entrega individual más grande fue de 830.000 acciones por parte de Mario J. Gabelli.

Tras la transacción, el grupo mantiene una minoría controladora de la clase preferente, conservando una influencia significativa en asuntos que requieren la aprobación de los accionistas preferentes. Todas las personas que informan ejercen poder exclusivo de voto y disposición sobre sus respectivas participaciones; no se reporta poder compartido. No se revelaron nuevos procedimientos legales ni cambios en los acuerdos de control.

Implicaciones para los inversores: Aunque la entrega reduce materialmente la propiedad absoluta, la participación colectiva del grupo sigue siendo alta en un 45%. La recompra a valor nominal (10 $) podría indicar un potencial limitado de aumento en la valoración actual de las preferentes y afectar la liquidez del flotante restante. Sin embargo, persiste una alineación continua de intereses entre las entidades Gabelli y los accionistas preferentes.

Gabelli Healthcare & Wellness Rx Trust (GRX) 우선주에 대한 Schedule 13D/A 6차 수정보고서는 Gabelli 관련 여러 법인 및 개인의 소유 현황을 업데이트하여 공개합니다.

총 소유 현황: 보고자들은 현재 1,514,000주 우선주를 보유하고 있으며, 이는 2025년 6월 30일 기준 총 발행주식 3,328,500주의 45.49%에 해당합니다. 주요 보유 내역은 다음과 같습니다:

  • Associated Capital Group (AC): 400,000주 – 12.02%
  • GAMCO Investors (GBL): 400,000주 – 12.02%
  • Mario J. Gabelli (개인): 400,000주 – 12.02%
  • Gabelli Foundation: 314,000주 – 9.43%

최근 거래 (2025년 6월 26일): 여러 법인이 펀드의 환매권에 따라 1,440,000주 우선주 (E 시리즈 및 G 시리즈)를 주당 10.00달러에 반환했습니다. 가장 큰 단일 반환은 Mario J. Gabelli가 830,000주를 반환한 것입니다.

거래 후, 그룹은 우선주 클래스에서 지배적 소수 지분을 유지하며, 우선주주 승인 필요 사안에 대해 상당한 영향력을 보유합니다. 모든 보고자는 각자의 보유 주식에 대해 단독 의결권 및 처분권을 행사하며, 공동 권한은 보고되지 않았습니다. 새로운 법적 절차나 지배구조 변경 사항은 공개되지 않았습니다.

투자자에 대한 시사점: 반환으로 절대 소유 지분은 크게 줄었으나, 그룹의 총 지분은 여전히 45%로 높은 수준입니다. 액면가(10달러)로의 환매는 현재 우선주 평가에서 상승 여력이 제한적일 수 있음을 시사하며, 잔여 유통물량의 유동성에 영향을 줄 수 있습니다. 그러나 Gabelli 관련 법인과 우선주주 간의 이해관계 일치는 계속 유지되고 있습니다.

Amendement n°6 au Schedule 13D/A concernant les Actions Préférentielles de Gabelli Healthcare & Wellness Rx Trust (GRX) révèle des informations mises à jour sur la détention de plusieurs entités et individus liés à Gabelli.

Détention globale : Les personnes déclarantes détiennent désormais 1 514 000 actions préférentielles, représentant 45,49 % des 3 328 500 actions en circulation au 30 juin 2025. Les positions clés incluent :

  • Associated Capital Group (AC) : 400 000 actions – 12,02 %
  • GAMCO Investors (GBL) : 400 000 actions – 12,02 %
  • Mario J. Gabelli (individu) : 400 000 actions – 12,02 %
  • Gabelli Foundation : 314 000 actions – 9,43 %

Transactions récentes (26 juin 2025) : Plusieurs entités ont cédé un total de 1 440 000 actions préférentielles (Séries E & G) à 10,00 $ par action dans le cadre du droit de rachat du Fonds visant à racheter jusqu’à 100 % de ses actions préférentielles cumulatives en circulation. La plus grande cession individuelle a été de 830 000 actions par Mario J. Gabelli.

Après la transaction, le groupe conserve une minorité contrôlante de la catégorie préférentielle, maintenant une influence significative sur les questions nécessitant l’approbation des actionnaires préférentiels. Toutes les personnes déclarantes exercent un pouvoir exclusif de vote et de disposition sur leurs participations respectives ; aucun pouvoir partagé n’est signalé. Aucun nouveau litige ni changement dans les accords de contrôle n’a été divulgué.

Implications pour les investisseurs : Bien que la cession réduise substantiellement la propriété absolue, la participation collective du groupe reste élevée à 45 %. Le rachat à la valeur nominale (10 $) pourrait indiquer un potentiel limité de hausse dans la valorisation actuelle des actions préférentielles et pourrait affecter la liquidité du flottant restant. Cependant, l’alignement continu des intérêts entre les entités Gabelli et les actionnaires préférentiels perdure.

Schedule 13D/A Änderung Nr. 6 für Gabelli Healthcare & Wellness Rx Trust (GRX) Vorzugsaktien offenbart aktualisierte Eigentumsinformationen für mehrere gabelli-nahe Unternehmen und Personen.

Gesamteigentum: Die meldenden Personen halten nun 1.514.000 Vorzugsaktien, was 45,49 % der 3.328.500 ausstehenden Aktien zum 30. Juni 2025 entspricht. Wichtige Positionen umfassen:

  • Associated Capital Group (AC): 400.000 Aktien – 12,02 %
  • GAMCO Investors (GBL): 400.000 Aktien – 12,02 %
  • Mario J. Gabelli (Einzelperson): 400.000 Aktien – 12,02 %
  • Gabelli Foundation: 314.000 Aktien – 9,43 %

Jüngste Transaktionen (26. Juni 2025): Mehrere Unternehmen gaben insgesamt 1.440.000 Vorzugsaktien (Serie E & Serie G) zu 10,00 $ pro Aktie im Rahmen des Rückkaufrechts des Fonds zurück, um bis zu 100 % seiner ausstehenden kumulativen Vorzugsaktien einzulösen. Die größte einzelne Rückgabe betrug 830.000 Aktien durch Mario J. Gabelli.

Nach der Transaktion behält die Gruppe eine kontrollierende Minderheit der Vorzugsklasse und behält erheblichen Einfluss auf Angelegenheiten, die die Zustimmung der Vorzugsaktionäre erfordern. Alle meldenden Personen üben alleinige Stimm- und Verfügungsgewalt über ihre jeweiligen Bestände aus; keine gemeinsame Macht wurde gemeldet. Es wurden keine neuen Rechtsverfahren oder Änderungen der Kontrollvereinbarungen offengelegt.

Auswirkungen für Investoren: Obwohl die Rückgabe den absoluten Eigentumsanteil deutlich reduziert, bleibt der kollektive Anteil der Gruppe mit 45 % hoch. Der Rückkauf zum Nennwert (10 $) könnte auf begrenztes Aufwärtspotenzial bei der aktuellen Vorzugsbewertung hinweisen und die Liquidität des verbleibenden Streubesitzes beeinflussen. Die fortgesetzte Interessenausrichtung zwischen den Gabelli-Einheiten und den Vorzugsaktionären bleibt jedoch bestehen.

Positive
  • Reporting group retains a significant 45.49 % stake, ensuring continued alignment with other preferred shareholders.
  • Redemption performed at full par value ($10), providing immediate liquidity to surrendering holders without discount.
Negative
  • Large reduction of 1.44 million shares suggests diminished absolute commitment by Gabelli entities.
  • Issuer cash outflow for redemption (details not provided) could pressure liquidity and future dividend coverage.

Insights

TL;DR: Gabelli entities cut preferred stake via fund put; still hold 45%, impact neutral.

The amendment shows a sizeable redemption—1.44 million shares—at $10.00, executed through the issuer’s contractual put right. Despite the reduction, the Gabelli complex maintains an influential 45% ownership. Redemption proceeds may reflect capital re-allocation rather than a bearish view, as the shares were put at mandatory terms, not open-market sales. No premium or discount was involved, limiting market-price signaling. Ownership concentration remains high, preserving potential board or voting leverage. Overall market impact is muted: free float increases modestly, but issuer cash outflow (not detailed here) may marginally pressure liquidity ratios. I assign a neutral (0) impact rating.

TL;DR: Large redemption improves holder liquidity but signals par-value ceiling.

The mass surrender implies holders preferred guaranteed par value over continued yield, suggesting limited upside in GRX preferreds above $10. The issuer’s willingness (or obligation) to redeem such volume indicates adequate cash or refinancing capacity, but investors should verify balance-sheet effects in subsequent filings. Remaining Gabelli alignment (45%) still supports governance continuity. From a portfolio perspective, this event is not a catalyst for common shares but worth monitoring for preferred liquidity and future coupon coverage. Rating 0 (neutral).

Emendamento No. 6 al Schedule 13D/A per le Azioni Preferenziali di Gabelli Healthcare & Wellness Rx Trust (GRX) rivela informazioni aggiornate sulla proprietà di più entità e individui legati a Gabelli.

Proprietà complessiva: Le Persone che Segnalano detengono ora 1.514.000 azioni preferenziali, pari al 45,49% delle 3.328.500 azioni in circolazione al 30 giugno 2025. Le posizioni principali includono:

  • Associated Capital Group (AC): 400.000 azioni – 12,02%
  • GAMCO Investors (GBL): 400.000 azioni – 12,02%
  • Mario J. Gabelli (individuale): 400.000 azioni – 12,02%
  • Gabelli Foundation: 314.000 azioni – 9,43%

Transazioni recenti (26 giugno 2025): Diverse entità hanno ceduto un totale di 1.440.000 azioni preferenziali (Serie E & Serie G) a 10,00 $ per azione nell’ambito del diritto di rimborso del Fondo per riscattare fino al 100% delle azioni preferenziali cumulative in circolazione. La singola cessione più rilevante è stata di 830.000 azioni da parte di Mario J. Gabelli.

Dopo la transazione, il gruppo mantiene una minoranza di controllo della classe preferenziale, conservando un’influenza significativa sulle questioni che richiedono l’approvazione degli azionisti preferenziali. Tutte le persone che segnalano esercitano potere di voto e decisionale esclusivo sulle rispettive partecipazioni; non è stato riportato alcun potere condiviso. Non sono stati divulgati nuovi procedimenti legali o cambiamenti negli accordi di controllo.

Implicazioni per gli investitori: Sebbene la cessione riduca in modo significativo la proprietà assoluta, la quota collettiva del gruppo resta elevata al 45%. Il riacquisto a valore nominale (10 $) potrebbe indicare un potenziale limitato di apprezzamento nell’attuale valutazione delle azioni preferenziali e influire sulla liquidità del flottante residuo. Tuttavia, permane un allineamento continuo degli interessi tra le entità Gabelli e gli azionisti preferenziali.

Enmienda No. 6 al Schedule 13D/A para las Acciones Preferentes de Gabelli Healthcare & Wellness Rx Trust (GRX) revela información actualizada sobre la propiedad de múltiples entidades e individuos relacionados con Gabelli.

Propiedad agregada: Las Personas que Informan ahora poseen 1.514.000 acciones preferentes, equivalentes al 45,49% de las 3.328.500 acciones en circulación al 30 de junio de 2025. Las posiciones clave incluyen:

  • Associated Capital Group (AC): 400.000 acciones – 12,02%
  • GAMCO Investors (GBL): 400.000 acciones – 12,02%
  • Mario J. Gabelli (individual): 400.000 acciones – 12,02%
  • Gabelli Foundation: 314.000 acciones – 9,43%

Transacciones recientes (26 de junio de 2025): Varias entidades entregaron un total de 1.440.000 acciones preferentes (Series E y G) a 10,00 $ por acción bajo el derecho del Fondo para redimir hasta el 100% de sus acciones preferentes acumulativas en circulación. La entrega individual más grande fue de 830.000 acciones por parte de Mario J. Gabelli.

Tras la transacción, el grupo mantiene una minoría controladora de la clase preferente, conservando una influencia significativa en asuntos que requieren la aprobación de los accionistas preferentes. Todas las personas que informan ejercen poder exclusivo de voto y disposición sobre sus respectivas participaciones; no se reporta poder compartido. No se revelaron nuevos procedimientos legales ni cambios en los acuerdos de control.

Implicaciones para los inversores: Aunque la entrega reduce materialmente la propiedad absoluta, la participación colectiva del grupo sigue siendo alta en un 45%. La recompra a valor nominal (10 $) podría indicar un potencial limitado de aumento en la valoración actual de las preferentes y afectar la liquidez del flotante restante. Sin embargo, persiste una alineación continua de intereses entre las entidades Gabelli y los accionistas preferentes.

Gabelli Healthcare & Wellness Rx Trust (GRX) 우선주에 대한 Schedule 13D/A 6차 수정보고서는 Gabelli 관련 여러 법인 및 개인의 소유 현황을 업데이트하여 공개합니다.

총 소유 현황: 보고자들은 현재 1,514,000주 우선주를 보유하고 있으며, 이는 2025년 6월 30일 기준 총 발행주식 3,328,500주의 45.49%에 해당합니다. 주요 보유 내역은 다음과 같습니다:

  • Associated Capital Group (AC): 400,000주 – 12.02%
  • GAMCO Investors (GBL): 400,000주 – 12.02%
  • Mario J. Gabelli (개인): 400,000주 – 12.02%
  • Gabelli Foundation: 314,000주 – 9.43%

최근 거래 (2025년 6월 26일): 여러 법인이 펀드의 환매권에 따라 1,440,000주 우선주 (E 시리즈 및 G 시리즈)를 주당 10.00달러에 반환했습니다. 가장 큰 단일 반환은 Mario J. Gabelli가 830,000주를 반환한 것입니다.

거래 후, 그룹은 우선주 클래스에서 지배적 소수 지분을 유지하며, 우선주주 승인 필요 사안에 대해 상당한 영향력을 보유합니다. 모든 보고자는 각자의 보유 주식에 대해 단독 의결권 및 처분권을 행사하며, 공동 권한은 보고되지 않았습니다. 새로운 법적 절차나 지배구조 변경 사항은 공개되지 않았습니다.

투자자에 대한 시사점: 반환으로 절대 소유 지분은 크게 줄었으나, 그룹의 총 지분은 여전히 45%로 높은 수준입니다. 액면가(10달러)로의 환매는 현재 우선주 평가에서 상승 여력이 제한적일 수 있음을 시사하며, 잔여 유통물량의 유동성에 영향을 줄 수 있습니다. 그러나 Gabelli 관련 법인과 우선주주 간의 이해관계 일치는 계속 유지되고 있습니다.

Amendement n°6 au Schedule 13D/A concernant les Actions Préférentielles de Gabelli Healthcare & Wellness Rx Trust (GRX) révèle des informations mises à jour sur la détention de plusieurs entités et individus liés à Gabelli.

Détention globale : Les personnes déclarantes détiennent désormais 1 514 000 actions préférentielles, représentant 45,49 % des 3 328 500 actions en circulation au 30 juin 2025. Les positions clés incluent :

  • Associated Capital Group (AC) : 400 000 actions – 12,02 %
  • GAMCO Investors (GBL) : 400 000 actions – 12,02 %
  • Mario J. Gabelli (individu) : 400 000 actions – 12,02 %
  • Gabelli Foundation : 314 000 actions – 9,43 %

Transactions récentes (26 juin 2025) : Plusieurs entités ont cédé un total de 1 440 000 actions préférentielles (Séries E & G) à 10,00 $ par action dans le cadre du droit de rachat du Fonds visant à racheter jusqu’à 100 % de ses actions préférentielles cumulatives en circulation. La plus grande cession individuelle a été de 830 000 actions par Mario J. Gabelli.

Après la transaction, le groupe conserve une minorité contrôlante de la catégorie préférentielle, maintenant une influence significative sur les questions nécessitant l’approbation des actionnaires préférentiels. Toutes les personnes déclarantes exercent un pouvoir exclusif de vote et de disposition sur leurs participations respectives ; aucun pouvoir partagé n’est signalé. Aucun nouveau litige ni changement dans les accords de contrôle n’a été divulgué.

Implications pour les investisseurs : Bien que la cession réduise substantiellement la propriété absolue, la participation collective du groupe reste élevée à 45 %. Le rachat à la valeur nominale (10 $) pourrait indiquer un potentiel limité de hausse dans la valorisation actuelle des actions préférentielles et pourrait affecter la liquidité du flottant restant. Cependant, l’alignement continu des intérêts entre les entités Gabelli et les actionnaires préférentiels perdure.

Schedule 13D/A Änderung Nr. 6 für Gabelli Healthcare & Wellness Rx Trust (GRX) Vorzugsaktien offenbart aktualisierte Eigentumsinformationen für mehrere gabelli-nahe Unternehmen und Personen.

Gesamteigentum: Die meldenden Personen halten nun 1.514.000 Vorzugsaktien, was 45,49 % der 3.328.500 ausstehenden Aktien zum 30. Juni 2025 entspricht. Wichtige Positionen umfassen:

  • Associated Capital Group (AC): 400.000 Aktien – 12,02 %
  • GAMCO Investors (GBL): 400.000 Aktien – 12,02 %
  • Mario J. Gabelli (Einzelperson): 400.000 Aktien – 12,02 %
  • Gabelli Foundation: 314.000 Aktien – 9,43 %

Jüngste Transaktionen (26. Juni 2025): Mehrere Unternehmen gaben insgesamt 1.440.000 Vorzugsaktien (Serie E & Serie G) zu 10,00 $ pro Aktie im Rahmen des Rückkaufrechts des Fonds zurück, um bis zu 100 % seiner ausstehenden kumulativen Vorzugsaktien einzulösen. Die größte einzelne Rückgabe betrug 830.000 Aktien durch Mario J. Gabelli.

Nach der Transaktion behält die Gruppe eine kontrollierende Minderheit der Vorzugsklasse und behält erheblichen Einfluss auf Angelegenheiten, die die Zustimmung der Vorzugsaktionäre erfordern. Alle meldenden Personen üben alleinige Stimm- und Verfügungsgewalt über ihre jeweiligen Bestände aus; keine gemeinsame Macht wurde gemeldet. Es wurden keine neuen Rechtsverfahren oder Änderungen der Kontrollvereinbarungen offengelegt.

Auswirkungen für Investoren: Obwohl die Rückgabe den absoluten Eigentumsanteil deutlich reduziert, bleibt der kollektive Anteil der Gruppe mit 45 % hoch. Der Rückkauf zum Nennwert (10 $) könnte auf begrenztes Aufwärtspotenzial bei der aktuellen Vorzugsbewertung hinweisen und die Liquidität des verbleibenden Streubesitzes beeinflussen. Die fortgesetzte Interessenausrichtung zwischen den Gabelli-Einheiten und den Vorzugsaktionären bleibt jedoch bestehen.

EUROPEAN EQUITY FUND, INC / MD false 0000791718 0000791718 2025-05-09 2025-05-09

As filed with the Securities and Exchange Commission on July 1, 2025

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 9, 2025

 

 

THE EUROPEAN EQUITY FUND, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   811-04632   26-0529973
(State or other Jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

875 Third Avenue

New York, NY 10022

(Address of principal executive offices)

Registrant’s telephone number, including area code: (212) 454-4500

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 


ITEM 8.01

OTHER EVENTS

On May 9, 2025, the Board of Directors of the Registrant approved (1) Articles of Amendment to the Registrant’s charter, which became effective June 30, 2025; and (2) Articles Supplementary regarding the Registrant’s election to no longer be subject to Section 3-803 of the Maryland General Corporation law, which became effective on June 30, 2025. The Articles of Amendment are filed as Exhibit 99.1 to this Report on Form 8-K. The Articles Supplementary are filed as Exhibit 99.2 to this Report on Form 8-K.

 

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

 

(d)

Exhibits.

 

Exhibit
Number

  

Description

99.1    Articles of Amendment to the Registrant’s charter as filed with the State Department of Assessments and Taxation of the State of Maryland on July 1, 2025
99.2    Articles Supplementary as filed with the State Department of Assessments and Taxation of the State of Maryland on July 1, 2025

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 1, 2025     The European Equity Fund, Inc.
   

/s/ John Millette

        Name:   John Millette
        Title:   Secretary

 

3

FAQ

How many GRX preferred shares do the Gabelli entities now own?

They collectively own 1,514,000 shares, representing 45.49 % of the class.

Which entity holds the largest individual GRX preferred position?

Several entities—Associated Capital Group, GAMCO Investors, and Mario Gabelli—each hold 400,000 shares (12.02 %).

What transactions occurred on 26 June 2025?

1.44 million preferred shares were surrendered at $10.00 under the Fund’s put right, reducing the group’s stake.

Does any reporting person share voting power over GRX preferred shares?

No. All reporting persons claim sole voting and dispositive power over their respective holdings.

What percentage of GRX preferred shares is still outstanding after the redemption?

The filing references 3,328,500 shares outstanding; the group now owns 45.49 %, implying 54.51 % remains with other holders.

Why were the shares surrendered rather than sold on the market?

The surrender was executed under the Fund’s contractual right to redeem up to 100 % of its cumulative preferred shares at par.
European Equity Fund

NYSE:EEA

EEA Rankings

EEA Latest News

EEA Latest SEC Filings

EEA Stock Data

67.26M
6.70M
0.1%
55.14%
0.05%
Asset Management
Financial Services
Link
Germany
Frankfurt am Main